Table 3.
Ranking of the importance of short-medium term treatment goals in IBD (mean scores and standard deviation).
| Crohn disease | Ulcerative colitis | ||
|---|---|---|---|
| Goals (order of importance)a | Score | Goals (order of importance)b | Score |
| Clinical remission | 1.65 (0.73) | Clinical response | 1.80 (1.65) |
| Clinical response | 1.95 (1.46) | Clinical remission | 1.96 (0.72) |
| Biomarkers normalization | 3.95 (1.39) | Biomarkers normalization | 3.98 (1.28) |
| Endoscopic response | 4.64 (1.28) | Endoscopic response | 4.71 (1.33) |
| Normalization of quality of life | 5.20 (1.78) | Normalization of quality of life | 4.76 (1.77) |
| Endoscopic remission | 5.47 (1.46) | Endoscopic remission | 5.55 (1.49) |
| Absence of disability | 5.89 (2.02) | Absence of disability | 5.78 (2.00) |
| Transmural remission | 8.04 (1.15) | Histologic remission | 7.45 (0.86) |
| Histologic remission | 8.22 (0.98) | - | - |
Abbreviation: IBD, inflammatory bowel disease.
a1, Most Important; 9, Least Important.
b1, Most Important; 8, Least Important.